Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saito, H.
Right arrow Articles by Kaibara, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saito, H.
Right arrow Articles by Kaibara, N.
Related Collections
Right arrow Prognostic factors
Annals of Surgical Oncology 9:450-456 (2002)
© 2002 Society of Surgical Oncology

ORIGINAL ARTICLES

The Expression of Murine Double Minute 2 Is a Favorable Prognostic Marker in Esophageal Squamous Cell Carcinoma Without p53 Protein Accumulation

Hiroaki Saito, MD, PhD, Shunichi Tsujitani, MD, Shinichi Oka, MD, Masahide Ikeguchi, MD, Michio Maeta, MD and Nobuaki Kaibara, MD

From the First Department of Surgery, Tottori University School of Medicine, Yonago, Japan.

Correspondence: Address correspondence and reprint requests to: Hiroaki Saito, MD, PhD, First Department of Surgery, Tottori University School of Medicine, 36-1 Nishi-cho, Yonago 683-8504, Japan; Fax: 81-859-34-8095; E-mail: KotoriSai10{at}aol.com

Background: Murine double minute 2 (MDM2) is an oncoprotein that inhibits the function of p53 tumor-suppressor protein. Although there have been a few reports on MDM2 gene abnormalities, there has been no investigation into expression of the product of this gene in esophageal squamous cell carcinoma. Thus, the clinicopathological and prognostic significance of the product of the MDM2 gene is as yet unknown.

Methods: MDM2 protein expression status was analyzed in surgically resected materials by immunohistochemical procedures.

Results: The expression of MDM2 significantly correlated inversely with tumor size, depth of invasion, lymph node metastasis, lymphatic vessel invasion, and stage of disease. However, the expression of MDM2 correlated with neither p53 protein accumulation status nor Ki-67 labeling index. The prognosis with MDM2-positive status was significantly better than that with MDM2-negative status for patients with p53-negative tumors, but not in those with p53-positive tumors. Moreover, multivariate analysis showed that the expression of MDM2 was an independent prognostic factor in patients with p53-negative tumors.

Conclusions: These findings indicate that MDM2 immunohistochemical analysis may provide useful information concerning the prognosis in esophageal squamous cell carcinoma patients with p53-negative tumors.

Key Words: Murine double minute 2 • p53 • Ki-67 • Esophageal carcinoma




This article has been cited by other articles:


Home page
 Mol. Cell. Biol.Home page
J.-Y. Yang, C. S. Zong, W. Xia, Y. Wei, M. Ali-Seyed, Z. Li, K. Broglio, D. A. Berry, and M.-C. Hung
MDM2 Promotes Cell Motility and Invasiveness by Regulating E-Cadherin Degradation.
Mol. Cell. Biol., October 1, 2006; 26(19): 7269 - 7282.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Society of Surgical Oncology.